Dihydrolipoamide dehydrogenase Recombinant Antbody Kit (KD-Validated)

Overview
Catalog #	bsm-90104r-50µL
Product Name	Dihydrolipoamide dehydrogenase Recombinant Antbody Kit (KD-Validated)
Applications	WB, FCM, IC
Specificity	Knockdown Validated
Reactivity	Human, Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	A synthesized peptide derived from human DLDH
Immunogen Range	450-509/509
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Affinity Purified
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	-20 °C
Target
Gene ID	1738
Swiss Prot	P09622
Synonyms	DLD; Dihydrolipoamide Dehydrogenase; OGDC-E3; DLDH; GCSL; LAD; E3; E3 Component Of Pyruvate Dehydrogenase Complex 2-Oxo-Glutarate Complex Branched Chain Keto Acid Dehydrogenase Complex; Dihydrolipoyl Dehydrogenase Mitochondrial; Glycine Cleavage System L Protein; EC 1.8.1.4; PHE3; Dihydrolipoamide Dehydrogenase (E3 Component Of Pyruvate Dehydrogenase Complex 2-Oxo-Glutarate Complex Branched Chain Keto Acid Dehydrogenase Complex); Epididymis Secretory Sperm Binding Protein; Glycine Cleavage System Protein L; Lipoamide Dehydrogenase; Lipoyl Dehydrogenase; Lipoamide Reductase; Diaphorase; EC 1.8.1 48; DLDD
Background	Cell Line: Hela Knockdown technology: shRNA Knockdown
Application Dilution
WB	1:300-5000
FCM	1:20-100
IC	1:1000